THERESE SARGENT: Open Payments
NPI 1851393433 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$58,643 in 100 payments from 7 companies in 2025. Trend: 2023 $106,449 · 2024 $51,632 · 2025 $58,643
Speaker / faculty: $29,832Travel & lodging: $15,410Consulting: $11,400Food & beverage: $2,002
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 63 | $32,908 |
| Johnson & Johnson Health Care Systems Inc. | 20 | $16,997 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $7,767 |
| United Therapeutics Corporation | 3 | $661 |
| Edwards Lifesciences Corporation | 1 | $213 |
| Merck Sharp & Dohme LLC | 2 | $83 |
| Sandoz Inc. | 1 | $14 |
Products named: UPTRAVI, OPSUMIT, Adempas, SAPIEN 3 Ultra RESILIA, TYVASO, TREPROSTINIL, OPSYNVI.
Industry payments across AZ — which companies pay providers there.
